Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | HOMB | CVI |
|---|---|---|
| Price | $28.57 | $56.94 |
| Change today | ▼ 0.35% | ▲ 3.85% |
| Market cap | $5.72B | $5.72B |
| Return, 3 months | +0.4% | +99.4% |
| Return, year to date | +5.2% | +125.2% |
| Return, 1 year | +4.4% | +55.9% |
| P/E (TTM) | 11.8 | 82.5 |
| P/B | 1.3 | 10.9 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | 2.91% | 0.18% |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | – | – |
| Analyst buy share | – | – |
| RSI (14) | 38 | 78 |
| 30-day volatility | 14.3% | 41.3% |
| Max drawdown, 1 year | -14.8% | -48.2% |
| Trend read | Leaning bearish | Strong uptrend |
| Analyst consensus | – | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
